David de Graaf
Chief Executive Officer Reverb Therapeutics Inc.
Seminars
Thursday 25th March 2027
Cytokine Engagement & Redirection for Targeted Enhancement of Regulatory T-Cell Function & Expansion
11:30 am
- A novel approach to expanding regulatory T-cells via endogenous cytokine capture and redirection
- Demonstration on how multispecific antibodies may overcome challenges associated with immunocytokines and other modalities